Seongjin Beauty Science (086710), under the leadership of CEO Lee Seong-ho, announced on the 10th that it achieved a consolidated revenue of 22.7 billion KRW in Q1 2026, marking a slight increase from 22.5 billion KRW in the same period last year. The operating profit stood at 1.5 billion KRW, reflecting a substantial improvement from the previous quarter's loss of 400 million KRW. However, the year-on-year decrease in operating profit can be attributed to increased fixed costs associated with the expansion of its ODM business and investments in global marketing for its proprietary brand, i-Recipe.

In terms of standalone performance, the company sustained a stable trajectory with 20.2 billion KRW in standalone revenue and an operating profit of 900 million KRW, which showcases a remarkable recovery from a loss of 800 million KRW in the previous quarter. This suggests operational resilience, underscoring effective cost management and the potential for improved profitability in the coming periods.

Seongjin Beauty Science has been actively enhancing its brand recognition for i-Recipe, having appointed Nmix’s Jiwoo as a brand ambassador in early 2026. This initiative is part of a broader strategic approach to bolster brand visibility while diversifying long-term revenue structures. With plans to capitalize on global distribution channels, the company expects that investments made in brand and business expansion during the first half of 2026 will yield positive results commencing in the latter half of the year.

Furthermore, the launch schedule for new OTC (over-the-counter) OEM/ODM products has been adjusted to the second half of 2026. This change reflects a strategic alignment with customer launch plans and market responsiveness, indicating the company's agility in adapting to evolving market conditions.

As part of its growth strategy, Seongjin Beauty Science is accelerating the establishment of international operations, having recently initiated the establishment of a corporation in Indonesia, following its expansions in Italy and the United States. The strategic focus on Indonesia is not only aimed at enhancing local responsiveness but also at scaling up the supply of high-functionality cosmetic ingredients, such as UV blocking agents and microbeads, thereby driving global ingredient sales.

While discussing the company's outlook, a representative from Seongjin Beauty Science stated, “The first half was marked by strategic investments focused on stabilizing ODM operations and brand marketing. We anticipate that from the second half onward, as cost structures stabilize and initial OTC supplies are integrated, along with revenue growth from Southeast Asian operations led by our Indonesian subsidiary, we will see accelerated improvements in annual performance.”